XML 28 R5.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - CAD ($)
$ in Thousands
Total
At-the-market agreement
Share Capital
Share Capital
At-the-market agreement
Warrants
Contributed Surplus
Accumulated Other Comprehensive Income
Accumulated Deficit
Equity balance at beginning of period at Dec. 31, 2019 $ (108)   $ 311,078   $ 3,618 $ 29,339 $ 464 $ (344,607)
Net loss and other comprehensive income (loss) (22,569)           (64) (22,505)
Issued pursuant to stock option plan (note 10) 241   385     (144)    
Issued pursuant to incentive share award plan (note 10) 0   732     (732)    
Issued pursuant to "At the Market" Agreement (note 9)   $ 40,038   $ 40,038        
Issued pursuant to warrant derivative exercised (note 9) 6,333   6,333          
Share-based compensation expense (note 10) 2,559         2,559    
Share issue costs (note 9) (1,742)   (1,742)          
Equity balance at end of period at Dec. 31, 2020 24,752   356,824   3,618 31,022 400 (367,112)
Net loss and other comprehensive income (loss) (26,316)           (12) (26,304)
Issued pursuant to stock option plan (note 10) 238   381     (143)    
Issued pursuant to incentive share award plan (note 10) 0   544     (544)    
Issued pursuant to "At the Market" Agreement (note 9)   34,168   34,168        
Issued pursuant to warrant derivative exercised (note 9) 687   687          
Share-based compensation expense (note 10) 3,826         3,826    
Share issue costs (note 9) (1,256)   (1,256)          
Equity balance at end of period at Dec. 31, 2021 36,099   391,348   3,618 34,161 388 (393,416)
Net loss and other comprehensive income (loss) (24,561)           274 (24,835)
Issued pursuant to stock option plan (note 10) 12   20     (8)    
Issued pursuant to incentive share award plan (note 10) 0   98     (98)    
Expiry of equity warrant agreement (note 9) 0       (3,618) 3,618    
Issued pursuant to "At the Market" Agreement (note 9)   $ 13,338   $ 13,338        
Share-based compensation expense (note 10) 2,378         2,378    
Share issue costs (note 9) (764)   (764)          
Equity balance at end of period at Dec. 31, 2022 $ 26,502   $ 404,040   $ 0 $ 40,051 $ 662 $ (418,251)